Unveiling a suspected dupilumab‐induced neuropathy in pediatric eosinophilic esophagitis

Documenti analoghi

• IL‐17, GAL‐10, and TGF‐β are promising noninvasive biomarkers of pediatric eosinophilic esophagitis
  di: Martina Votto, et al.
  Pubblicazione: (2024)
• Systematic review of feeding difficulties in children with eosinophilic esophagitis: An EAACI Task Force report
  di: Maria Ruano‐Zaragoza, et al.
  Pubblicazione: (2025)
• Use of dupilumab for atopic dermatitis in pediatric and young adult patients with inborn errors of immunity
  di: Paola Zangari, et al.
  Pubblicazione: (2024)
• Urinary eosinophil‐derived neurotoxin is associated with reduced lung function in pediatric asthma
  di: Jimmy Omony, et al.
  Pubblicazione: (2024)
• Off‐label use of dupilumab in the management of pediatric urticaria vasculitis: A promising therapeutic choice
  di: Shan Wang, et al.
  Pubblicazione: (2025)